Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed FCF Margin for 6 consecutive years, with 11.98% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin rose 4361.0% year-over-year to 11.98%, compared with a TTM value of 20.59% through Sep 2025, down 6487.0%, and an annual FY2024 reading of 56.75%, up 13742.0% over the prior year.
  • FCF Margin was 11.98% for Q3 2025 at Fennec Pharmaceuticals, up from 38.19% in the prior quarter.
  • Across five years, FCF Margin topped out at 49177.78% in Q2 2021 and bottomed at 332.56% in Q1 2023.
  • Average FCF Margin over 5 years is 3872.02%, with a median of 34.91% recorded in 2025.
  • The sharpest move saw FCF Margin tumbled -525670bps in 2023, then surged 47957bps in 2024.
  • Year by year, FCF Margin stood at 49177.78% in 2021, then plummeted by -98bps to 744.2% in 2022, then tumbled by -107bps to 49.92% in 2023, then surged by 63bps to 18.6% in 2024, then skyrocketed by 164bps to 11.98% in 2025.
  • Business Quant data shows FCF Margin for FENC at 11.98% in Q3 2025, 38.19% in Q2 2025, and 49.34% in Q1 2025.